Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

20.0%

2 terminated/withdrawn out of 10 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT06216756Not ApplicableRecruiting

Evaluating Cryopreserved Osteochondral Allograft Cores for the Treatment of Osteochondral Lesions in the Knee

Role: lead

NCT03873545Active Not Recruiting

Prospective Evaluation of ProChondrix CR for Repair of Articular Cartilage Defects on Femoral Condyle and Patella

Role: lead

NCT04684901Not ApplicableEnrolling By Invitation

Effectiveness of AlloWrap® for the Reduction of Inflammation in ACDF Procedures

Role: lead

NCT06853964Active Not Recruiting

Retrospective Study of AlloMend Acellular Dermal Matrix (ADM) Allograft and Pre-Pectoral Breast Reconstruction

Role: lead

NCT04301258Terminated

ProChondrix® CR Articular Cartilage Restoration Evaluation (PACE) Registry

Role: lead

NCT05744414Active Not Recruiting

Histological Analysis of AlloMend® Acellular Dermal Matrix Used in Breast Implant Surgeries

Role: lead

NCT06512259Recruiting

AlloMend Acellular Dermal Matrix Allograft in Pre-Pectoral Breast Reconstruction

Role: lead

NCT04615117Unknown

An Outcomes Study Utilizing Allomend(R) HD for Superior Capsular Reconstruction

Role: collaborator

NCT04162639Phase 4Withdrawn

The Relationship Between Cadaveric Allograft Skin and HLA-Sensitivity in Burn Patients

Role: collaborator

NCT01413061Not ApplicableCompleted

Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft

Role: lead

All 10 trials loaded